Great work from the Oncosil team in Q4, however sales in Q4 a bit behind expectations given recent break even remarks at Webinar.
What then is responsible for recent 100% SP appreciation and continued strength? - certainly not a pump.
Besides recent board addition with PH and capital injection by Pengana, I believe there is something else in the bush.
A bid perhaps?
Do your own research or ask your financial advisor.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.010(1.05%) |
Mkt cap ! $13.65M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.03 | 96.0¢ | $12.69K | 13.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1185 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 7827 | 1 |
View Market Depth
| Last trade - 10.30am 18/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |